www.bectastx.com

The company develops monoclonal antibody therapies that enhance immune response against various cancer types by combining antibodies with precision insights from pre-clinical studies. This approach aims to improve treatment efficacy and patient outcomes in oncology.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

The company develops monoclonal antibody therapies that enhance immune response against various cancer types by combining antibodies with precision insights from pre-clinical studies. This approach aims to improve treatment efficacy and patient outcomes in oncology.